News
The consumer privacy ombudsman in 23andMe’s sale of customers’ genetic data is defending his choice of counsel against ...
North Carolina Attorney General Jeff Jackson successfully ensures 23-and-Me customers’ sensitive genetic information remains ...
SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ('23andMe” or the 'Company”) (OTC: MEHCQ), a genetics-led consumer healthcare company, today announced that it has received ...
Customer Data Rights: TTAM will honor 23andMe’s existing policies that allow individuals to delete their account and genetic data and opt-out of research in perpetuity; ...
23andMe said in the June 13 press release that TTAM would continue the policy of allowing users to delete their account and genetic data as well as opt-out of research in perpetuity.
About 23andMe 23andMe is a genetics-led consumer healthcare and biotechnology company empowering a healthier future. For more information, please visit www.23andme.com. About TTAM Research Institute ...
Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...
TTAM Research Institute, led by Anne Wojcicki, to acquire nearly all of 23andMe’s assets for $305 million. The deal tops a previous $256 million offer from Regeneron Pharmaceuticals.
TTAM Research Institute was set up in May by Anne Wojcicki, a co-founder and former CEO of 23andMe, to acquire the company's assets and use the DNA data for medical research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results